We recently compiled a list of the 10 Firms Shine Amid Market Slump. In this article, we are going to take a look at where ...

The Gurugram-headquartered company, which is eyeing an initial public offering (IPO) and is in the planning stages, recently ...

Saturdays budget clarifies asset sales tax for domestic investors, potentially reducing litigation. This and more in todays ...

Previously, the reading of the Income Tax Act led to proceeds from exits to be considered business income for domestic ...

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson's venture capital arm, is considering a ...

Mike’s got more than 30 years’ experience in financial services,” says Pickerell. “He’s entrepreneurial and has good connections with clients. He’s been on our radar screen for some time.” Hong ...

(Reuters) -Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion. Shares of the ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

Private equity will have a more positive 2025 than it's had recent years, and institutional investors will likely turn their ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

BloombergNEF says in a new report that global clean energy investment reached $2.1 trillion in 2024, more than doubling 2020 ...